Nantahala Capital Management »

Eagle Pharmaceuticals shares owned by Nantahala Capital Management

Quarter-by-quarter ownership of Eagle Pharmaceuticals (EGRX) shares owned by Nantahala Capital Management from 13F filings

Historical chart of Nantahala Capital Management investment in Eagle Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Eagle Pharmaceuticals held by Nantahala Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Eagle Pharmaceuticals by Nantahala Capital Management

Quarter filed Position value Share count Share price at filing
2024-06-30 $17M 3.0M 5.60
2024-03-31 $6.6M 1.3M 5.24

More positions owned by Nantahala Capital Management

Ishares Tr Russell 2000 Etf (IWM)
Ishares Tr Russell 2000 Etf (IWM)
Eli Lilly & Co. Put Option (LLY)
Eli Lilly & Co. Put Option (LLY)
Soleno Therapeutics (SLNO)
Soleno Therapeutics (SLNO)
Establishment Labs Holdings Ord (ESTA)
Establishment Labs Holdings Ord (ESTA)
Spdr Ser Tr S&p Biotech (XBI)
Spdr Ser Tr S&p Biotech (XBI)
Peloton Interactive Cl A Com (PTON)
Peloton Interactive Cl A Com (PTON)
Grand Canyon Education Put Option (LOPE)
Grand Canyon Education Put Option (LOPE)
Imax Corp Cad (IMAX)

View all positions for Nantahala Capital Management

Top funds holding Eagle Pharmaceuticals

Nantahala Capital Management
AIGH Capital Management
Citigroup
AQR Capital Management
Vanguard Group
BlackRock
Bank of America Corporation
Morgan Stanley
LSV Asset Management
Renaissance Technologies
Two Sigma Advisers
Marshall Wace
J. Goldman & Co
Assenagon Asset Management
Perceptive Advisors

View all funds holding Eagle Pharmaceuticals